Education
About Us
Working with TipRanks
Follow Us
Neuphoria Therapeutics (NEUP)
NASDAQ:NEUP
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | AU$ 23.95M | AU$ 0.00 | AU$ 0.00 | - | AU$ 0.00 |
| Gross Profit | AU$ 22.94M | AU$ -992.56K | AU$ -671.42K | AU$ 0.00 | AU$ -1.69M |
| Operating Income | AU$ -1.73M | AU$ -26.79M | AU$ -22.26M | AU$ -28.60M | AU$ -12.95M |
| EBITDA | AU$ -268.02K | AU$ -22.33M | AU$ -21.54M | AU$ -28.03M | AU$ -6.63M |
| Net Income | AU$ -565.77K | AU$ -23.19M | AU$ -21.65M | AU$ -22.94M | AU$ -8.65M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | AU$ 14.21B | AU$ 12.61M | AU$ 8.06M | AU$ 23.09M | AU$ 21.41M |
| Total Assets | AU$ 28.59B | AU$ 27.65M | AU$ 19.39M | AU$ 44.93M | AU$ 40.77M |
| Total Debt | AU$ 116.31M | AU$ 272.74K | AU$ 257.55K | AU$ 477.15K | AU$ 652.04K |
| Net Debt | AU$ -14.09B | AU$ -12.34M | AU$ -7.80M | AU$ -22.61M | AU$ -20.76M |
| Total Liabilities | AU$ 9.59B | AU$ 10.16M | AU$ 4.74M | AU$ 5.78M | AU$ 5.01M |
| Stockholders' Equity | AU$ 19.00B | AU$ 17.49M | AU$ 14.65M | AU$ 39.15M | AU$ 35.76M |
| Cash Flow | |||||
| Free Cash Flow | AU$ 77.23M | AU$ -14.68M | AU$ -9.85M | AU$ -14.97M | AU$ -5.67M |
| Operating Cash Flow | AU$ 77.23M | AU$ -14.68M | AU$ -9.85M | AU$ -14.97M | AU$ -5.66M |
| Investing Cash Flow | AU$ 0.00 | AU$ 0.00 | AU$ 0.00 | AU$ 427.68K | AU$ -60.26K |
| Financing Cash Flow | AU$ 1.53B | AU$ 15.11M | AU$ 2.60M | AU$ 18.57M | AU$ 23.71M |
Neuphoria Therapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.